Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004650390 | SCV005141141 | uncertain significance | Inborn genetic diseases | 2024-05-20 | criteria provided, single submitter | clinical testing | The c.1654C>T (p.P552S) alteration is located in exon 2 (coding exon 1) of the NR3C2 gene. This alteration results from a C to T substitution at nucleotide position 1654, causing the proline (P) at amino acid position 552 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038760 | SCV005663054 | uncertain significance | Pseudohyperaldosteronism type 2; Autosomal dominant pseudohypoaldosteronism type 1 | 2024-02-29 | criteria provided, single submitter | clinical testing |